Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free IKT Stock Alerts $1.91 +0.37 (+24.03%) (As of 01:39 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Inhibikase Therapeutics Stock Price Performance5 Day Performance+45.80%1 Month Performance-12.98%3 Month Performance-19.41%6 Month Performance+103.19%Year-To-Date Performance+50.39%1 Year Performance-51.77% Receive IKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself IKT Stock Chart for Wednesday, May, 15, 2024 IKT Chart by TradingView Inhibikase Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$1.36$1.52+11.76%$1.60$1.3648,090 shs$9.85 million05/13/2024$1.31$1.36+3.82%$1.40$1.309,931 shs$8.81 million05/10/2024$1.36$1.31-3.68%$1.44$1.3055,165 shs$8.49 million05/09/2024$1.40$1.36-2.86%$1.39$1.3534,612 shs$8.81 million05/08/2024$1.26$1.40+11.11%$1.55$1.3134,551 shs$9.07 million05/07/2024$1.29$1.26-2.33%$1.30$1.2030,515 shs$8.17 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$1.39$1.29-7.19%$1.45$1.2971,291 shs$8.36 million05/03/2024$1.34$1.39+3.73%$1.51$1.3346,964 shs$9.01 million05/02/2024$1.35$1.34-0.74%$1.40$1.2969,386 shs$8.68 million05/01/2024$1.47$1.35-8.16%$1.45$1.3594,289 shs$8.74 million04/30/2024$1.59$1.47-7.55%$1.60$1.4355,165 shs$9.53 million04/29/2024$1.71$1.59-7.02%$1.76$1.5940,155 shs$10.30 million04/26/2024$1.86$1.71-8.06%$1.82$1.6798,983 shs$11.08 million04/25/2024$1.87$1.86-0.53%$1.90$1.7121,378 shs$12.05 million04/24/2024$1.58$1.87+18.35%$1.87$1.5462,107 shs$12.12 million04/23/2024$1.37$1.58+15.33%$1.60$1.4479,090 shs$10.24 million04/22/2024$2.04$1.37-32.84%$1.96$1.29367,713 shs$8.88 million04/19/2024$2.10$2.04-2.86%$2.13$2.0252,727 shs$13.22 million04/18/2024$2.13$2.10-1.41%$2.15$2.0427,598 shs$13.61 million04/17/2024$2.16$2.13-1.39%$2.20$2.1137,008 shs$13.80 million04/16/2024$2.20$2.16-1.59%$2.30$2.1312,949 shs$14.00 million04/15/2024$2.19$2.20+0.23%$2.25$2.1427,860 shs$14.22 million04/12/2024$2.25$2.19-2.67%$2.22$2.1531,317 shs$14.19 million04/11/2024$2.19$2.25+2.74%$2.25$2.1524,619 shs$14.58 million04/10/2024$2.13$2.19+2.82%$2.20$2.0928,732 shs$14.19 million04/09/2024$2.21$2.13-3.62%$2.20$2.0524,120 shs$13.80 million04/08/2024$2.20$2.21+0.45%$2.29$2.1534,726 shs$14.32 million04/05/2024$2.20$2.20$2.27$2.1542,009 shs$14.26 million04/04/2024$2.15$2.20+2.33%$2.27$2.1550,804 shs$14.26 million04/03/2024$2.15$2.15$2.28$2.0926,489 shs$13.93 million04/02/2024$2.16$2.15-0.46%$2.29$2.1246,468 shs$13.93 million04/01/2024$2.16$2.16$2.28$2.0167,763 shs$14.00 million03/29/2024$2.16$2.16$2.44$2.0897,891 shs$13.33 million03/28/2024$2.30$2.16-6.09%$2.44$2.0897,781 shs$13.33 million03/27/2024$2.29$2.30+0.44%$2.32$2.2514,636 shs$14.19 million03/26/2024$2.21$2.29+3.62%$2.39$2.2140,390 shs$14.13 million03/25/2024$2.23$2.21-0.90%$2.35$2.2030,251 shs$13.64 million03/22/2024$2.21$2.23+0.90%$2.25$2.1418,974 shs$13.76 million03/21/2024$2.05$2.21+7.80%$2.30$1.9250,973 shs$13.64 million03/20/2024$1.93$2.05+6.22%$2.10$1.9171,762 shs$12.65 millionTrump’s Former Wingman Bets Big on AI (Ad)One of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here.03/19/2024$2.01$1.93-3.98%$2.02$1.8175,747 shs$11.91 million03/18/2024$2.11$2.01-4.74%$2.17$1.9689,529 shs$12.40 million03/15/2024$2.13$2.11-0.94%$2.21$2.0536,505 shs$13.02 million03/14/2024$2.23$2.13-4.48%$2.30$2.1147,591 shs$13.15 million03/13/2024$2.27$2.23-1.76%$2.35$2.2129,315 shs$13.77 million03/12/2024$2.43$2.27-6.58%$2.42$2.1147,513 shs$14.01 million03/11/2024$2.47$2.43-1.62%$2.46$2.2937,130 shs$14.99 million03/08/2024$2.42$2.47+2.07%$2.49$2.3831,667 shs$15.24 million03/07/2024$2.41$2.42+0.41%$2.49$2.2944,393 shs$14.93 million03/06/2024$2.38$2.41+1.26%$2.41$2.2355,099 shs$14.87 million03/05/2024$2.25$2.38+5.78%$2.44$2.1973,944 shs$14.69 million03/04/2024$2.15$2.25+4.65%$2.25$2.0950,020 shs$13.89 million03/01/2024$2.16$2.15-0.46%$2.22$2.0779,263 shs$13.27 million02/29/2024$2.22$2.16-2.70%$2.35$2.1462,871 shs$13.33 million02/28/2024$2.26$2.22-1.77%$2.31$2.1167,652 shs$13.70 million02/27/2024$2.22$2.26+1.80%$2.34$2.1452,241 shs$13.94 million02/26/2024$2.14$2.22+3.74%$2.22$2.0372,519 shs$13.70 million02/23/2024$2.18$2.14-1.83%$2.23$2.0458,096 shs$13.20 million02/22/2024$2.22$2.18-1.80%$2.40$2.02138,394 shs$13.45 million02/21/2024$2.28$2.22-2.63%$2.38$2.1252,071 shs$13.70 million02/20/2024$2.36$2.28-3.39%$2.41$2.1852,152 shs$14.07 million02/19/2024$2.36$2.36$2.45$2.12136,000 shs$14.56 million02/16/2024$2.37$2.36-0.42%$2.45$2.12135,957 shs$14.56 million02/15/2024$2.54$2.37-6.69%$2.60$2.37155,561 shs$14.63 million02/14/2024$2.47$2.54+2.83%$2.60$2.40160,574 shs$15.68 million Related Companies: NSTGQ Stock Price Chart SRNE Stock Price Chart ONVO Stock Price Chart PALI Stock Price Chart CELZ Stock Price Chart TTNP Stock Price Chart BCDA Stock Price Chart GENE Stock Price Chart CHRO Stock Price Chart FRTX Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBill Clinton Backing Biden Replacement???The Freeport SocietyTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow to Play the AI and Crypto Markets in One SwingWeiss Ratingsis this a buy and hold stock?Tips4Traders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.